(May 21, 2024, 1:37 PM EDT) -- WASHINGTON, D.C. — The U.S. Food and Drug Administration filed a brief with the U.S. Supreme Court opposing a vape company’s petition for a writ of certiorari, arguing that it need not review a Third Circuit U.S. Court of Appeals ruling upholding FDA’s ban of the company’s products and should instead grant certiorari in a petition it has filed challenging a Fifth Circuit U.S. Court of Appeals ruling on a similar matter....